KRTL Holding Group, Inc. (OTC: KRTL) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc., an international research, and development company, has appointed Dr. Malcolm A. Leissring as its founding Chief Science Officer. "I am honored to be a part of this vibrant team of experts with such complementary expertise. The future indeed looks very bright for us," said Dr. Leissring.
top of page
bottom of page